Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	#o	#f	T	TVal	Price	Qty	oc	Own	H
3/27/25 08:13	3/26/25	VNRX	Volitionrx Ltd	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	7	16	P	637	0.5960	1,068	12	10,351	D
3/19/25 16:38	3/17/25	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	4	P.d	149	3.73	40	37	149	D
2/11/25 19:00	2/7/25	OCX	Oncocyte Corp	CA	Health	Diagn	In Vitro & In Vivo Diagnostic	5	14	P.dm	24,453	2.38	10,291	64	26,331	D
1/16/25 15:28	1/16/25	NEOG	Neogen Corp	MI	Health	Diagn	In Vitro & In Vivo Diagnostic	5	8	P	1,331	12.29	108	35	422	D
12/13/24 16:12	12/11/24	QDEL	Quidelortho Corp		Health	Diagn	In Vitro & In Vivo Diagnostic	2	2	P	350	42.72	8	207	12	I
11/12/24 08:01	11/11/24	CLDX	Celldex Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	P	308	26.82	12	40	40	D
10/9/24 13:18	9/6/24	CDIO	Cardio Diagnostics Holdings, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	3	7	P	130	0.2897	448	14	3,565	D
7/16/24 21:13	7/12/24	TKNO	Alpha Teknova, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	5	5	P.m	15,206	1.24	12,231	83	26,995	D
7/11/24 17:15	5/31/24	AWH	Aspira Women'S Health Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	2	5	P.d	40	0.7659	52	3	1,989	D
3/8/24 11:24	3/6/24	CATX	Perspective Therapeutics, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	1	1	P	57,409	0.9500	60,431	107	116,773	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person